Todd C Davis
CIK 1392029 · Chief Executive Officer · last filed 2026-04-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$92.77M
Companies
6
Total Filings
77
Lifetime Open-Market Net
-$5.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | 1,520,778 | $27.50 | $41.82M | $0 | 2 | 2026-04-01 |
| LGND | Chief Executive Officer | 199,381 | $255.54 | $50.95M | -$5.35M | 49 | 2026-03-27 |
| PVLA | Director | — | $108.81 | — | $0 | 2 | 2025-06-11 |
| Pelthos Therapeutics Inc. (CHRO) Delisted | Director | 29,167 | $13.50 | $393.8K | $0 | 3 | 2024-11-15 |
| Vaxart, Inc. (VXRT) Delisted | Director | 125,905 | $0.32 | $40.3K | -$196.5K | 7 | 2022-08-08 |
| ARTES MEDICAL INC (ARTE) Delisted | Director | — | $10.73 | — | $0 | 3 | 2008-02-15 |
Recent Filings · Page 2 of 8
77 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-19 | LGND | Mixed | +7,332 | -$1.61M | EDGAR |
| 2024-12-17 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2024-11-15 | Pelthos Therapeutics Inc. (CHRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-09 | LGND | Buy (P) | +2,500 | $243.5K | EDGAR |
| 2024-07-02 | LGND | Other (J) | +350 | $21.2K | EDGAR |
| 2024-06-18 | Pelthos Therapeutics Inc. (CHRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | LGND | Exer (M) | +16,015 | $919.1K | EDGAR |
| 2024-02-29 | LGND | Grant (A) | +32,436 | $0 | EDGAR |
| 2024-02-23 | Pelthos Therapeutics Inc. (CHRO) Delisted | Mixed | +29,167 | $140.0K | EDGAR |
| 2024-02-16 | LGND | Tax (F) | −1,381 | -$103.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.